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Management of unresolved, recurrent, and/or
contralateral neurogenic symptoms in patients
following first rib resection and scalenectomy
Danielle H. Rochlin, BA,a Kendall C. Likes,a Marta M. Gilson, PhD,b Paul J. Christo, MD, MBA,c and
Julie A. Freischlag, MD,a Baltimore, Md
Background: Surgical treatment for neurogenic thoracic outlet syndrome does not always yield successful outcomes. The
purpose of this study was to describe patients with unresolved, recurrent, and/or contralateral symptoms following first
rib resection and scalenectomy (FRRS) and to determine therapies for improving their outcomes.
Methods: Data on 161 neurogenic thoracic outlet syndrome patients (182 FRRS procedures) were prospectively collected
from 2003 to 2011 and retrospectively reviewed for evidence of unresolved, recurrent, and/or contralateral neurogenic
symptoms following FRRS. Demographic and clinical characteristics, interventions, and outcomes were compared
between these patients and those with a successful result.
Results: Twenty-three patients (24 FRRS) had unresolved symptoms at a mean of 16.1  14.7 postoperative months.
Compared with successes, these patients were older (mean age, 45 vs 38 years; P .002) and active smokers (33% vs 13%;
P  .031), with a longer duration of symptoms (90 vs 48 months; P  .005). They had higher rates of chronic pain
syndromes (67% vs 14%; P< .001), neck and/or shoulder comorbidities (58% vs 22%; P< .001), preoperative opioid use
(67% vs 31%; P .001), and preoperative Botox injections (46% vs 20%; P .009) with less relief (18% vs 64%; P .014).
Sixteen patients had recurrent symptoms at a mean of 12.1 9.7 postoperative months. These patients had more chronic
pain syndromes (38%; P .028) and neck and/or shoulder comorbidities (50%; P .027), with recurrence secondary to
scar tissue (69%; P < .001) and reinjury (31%; P  .002). Postoperative treatments for both groups included physical
therapy and local injections, where six unresolved (26%) and 13 recurrent (81%) patients achieved freedom from opioids
at the end of the follow-up period. Twenty-one patients had contralateral symptoms and underwent secondary FRRS at
a mean of 15.0 months (range, 7-30 months) following primary FRRS. The first operation was successful in 90% of cases.
Conclusions: Patients with unresolved symptoms are older, active smokers with more comorbid pain syndromes, neck
and/or shoulder disease, and a longer symptom duration. These patients face a more difficult recovery, whereas patients
with recurrent symptoms are well managed with physical therapy and Botox injections. Patients with contralateral
symptoms at >1 year are effectively treated with secondary FRRS. Patients must be followed closely after FRRS to
determine if additional interventions are necessary to ensure successful results. ( J Vasc Surg 2012;56:1061-8.)
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hThoracic outlet syndrome (TOS) is a condition that
results in compression of nerves of the brachial plexus (95%
of cases), the subclavian vein (4%-5% of cases), and/or the
subclavian artery (1% of cases) during passage through
the thoracic outlet. The most common subtype, neuro-
genic thoracic outlet syndrome (NTOS), often presents in
adults aged 20 to 40 years, with a greater prevalence among
women (3.5:1). Patients often have a history of chronic
repetitive motion or trauma with symptoms that include
weakness, paresthesia, and/or pain in the upper extremity,
in addition to cold intolerance and occipital headaches.1-3
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http://dx.doi.org/10.1016/j.jvs.2012.03.262onservative management of NTOS involves physical ther-
py, lifestyle modification, and anesthetic and/or steroid
njections. First rib resection and scalenectomy (FRRS) is
onsidered the gold standard treatment for the 30% to 40%
f patients that fail conservative management and is com-
only performed by a transaxillary or supraclavicular ap-
roach.4
Although the current cornerstone of treatment, surgery
oes not yield successful results in all patients. Relief of symp-
oms following anterior scalene block with local anesthetic is
onsidered a clinical indicator of good surgical candidacy, yet
oor outcomes among some patients with positive blocks
uggest a role for other factors.5 Improvement in short-term
unctional outcomes in appropriately selected patients follow-
ng FRRS has been well documented, yet the characteristics
ndmanagement of patients who do not benefit from surgical
ntervention remain understudied.6 The purpose of our study
as to describe the presentation and management of patients
ith unresolved or recurrent symptoms, which signify no
mprovement following FRRS. Contralateral symptoms were
lso reviewed to assess patients requiring bilateral surgeries for
uality-of-life improvement. While several published studies
ave reported limited collections of factors associated with
oor surgical outcomes, we have examined a wider variety of
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October 20121062 Rochlin et alclinical and demographic characteristics in a larger, consistent
subset of NTOS patients. Furthermore, our study is unique in
that predictors of poor outcomes are analyzed in the context
of surgical decision-making and formulation of postoperative
treatment plans specific to the outcome.
METHODS
Study participants. With approval from the Institu-
tional Review Board at Johns Hopkins Hospital (Baltimore,
Md), NTOS patients who had been treated by transaxillary
FRRS at JohnsHopkins from 2003 to 2010were determined
by review of a prospectively compiled database (maintained by
the Johns Hopkins Division of Vascular Surgery and Endo-
vascular Therapy). All patients had failed conservative treat-
ment with physical therapy and elected to undergo surgery.
Patients were selected for FRRS if their history and physical
were consistentwith a diagnosis ofNTOS.We rely on a tender
scalene muscle, a positive elevated arm stress test, and no
physical evidence of other etiology. We may also utilize ante-
rior scalene block with bupivacaine to confirm a diagnosis of
NTOS. Patients were eligible for inclusion if they were 18
years or older, had not undergone previous FRRS on the
affected side, were more than 1 year postoperative, and had
sufficient follow-up for clinical assessment. All patients com-
pleted at least 8 weeks of physical therapy.
Clinical assessment. Symptoms following each FRRS
procedure were classified as resolved, unresolved, or recur-
rent based on clinical assessment during postoperative
office visits. Symptoms were classified as resolved if the
clinician believed that FRRS had relieved the patient’s
TOS-related impairment and/or discomfort in accordance
with best clinical practice; these cases were considered
successful outcomes. In contrast, a classification of unresolved
was used to designate symptoms that persisted postoperatively
and failed to meet clinically acceptable standards of relief by
the end of the follow-up period. Symptoms following FRRS
were classified as recurrent if impairment and/or discomfort
reappeared following initial resolution. In cases of both unre-
solved and recurrent symptoms, postoperative symptoms
were similar to the preoperative presentation. Unresolved and
recurrent classifications were secondarily categorized as im-
proved or not improved, based on evidence of progressive
symptom resolution during the postoperative period. Patients
who underwent a secondary FRRS for contralateral NTOS
symptoms presenting before or after primary FRRS were
termed bilateral patients. Symptoms following each FRRS
procedure in these patients were independently classified as
resolved, unresolved, or recurrent.
Data collection. Demographic and clinical patient data
were obtained from review of the database and patients’
electronic medical records. Patient factors contained within
the database include age, gender, race, etiology of NTOS
(trauma or repetitive motion), length of symptoms, and relief
from anterior scalene block with bupivacaine. Additional fac-
tors extracted from review of patient charts included smoking
status, preoperative interventions, preoperative medications,
relief from computed tomography (CT)-guided Botox injec-
tion, peri- or postoperative complications, and postoperative snterventions. Comorbidities such as chronic pain syndromes,
hich include conditions causing persistent bodily pain and
ervical spine and/or shoulder injury, were also noted. Relief
rom anterior scalene block was defined as 50% symptom
esolution immediately after injection, with the upper extrem-
ty in a resting and/or stress position. Relief from Botox
njection was determined by the patient’s subjective assess-
ent of symptom relief within 3 months of injection. Each
rocedure involved a single injection of 20 units of Botox into
he anterior scalene muscle following injection with radio-
raphic contrast, with CT used to assess needle position and
pread of Botox throughout the muscle after injection. Fol-
ow-up time was defined as the number of months between
urgical intervention and the patient’s most recent office visit.
Statistical methods. Analysis of variance, 2 test,
isher exact test, and nonparametric tests (Kruskal-
allis) were used to determine whether differences in patient
actors were associated with FRRS outcome. Statistical signif-
cance was defined as a P value .05. Statistical analyses
ere performed with the use of SAS software, version 9.2
SAS Institute Inc,Cary,NC).Analyseswere conducted at the
atient level (n 161) and the FRRS level (n 182).
ESULTS
A total of 161 eligible NTOS patients were treated with
82 FRRS from 2003 to 2010. Twenty-one patients pre-
ented with contralateral symptoms and underwent bilat-
ral FRRS procedures. The study population included 121
emales and 40 males, with a collective mean age of 38.8
ears. Mean overall follow-up time for the 182 FRRS was
2.8  12.0 months. An overview of FRRS by clinical
lassification is illustrated in Fig 1. Tables I and II compare
RRS characteristics and postoperative course by clinical
ssessment, respectively.
Resolved symptoms. One hundred forty-two FRRS
128 patients) yielded resolved symptoms at amean of 11.3
0.8 postoperative months. Mean age was 37.8 years, with
08 (76.1%) FRRS procedures performed on females and
9 (13.4%) on active smokers. Average length of symptoms
t initial presentation (available for 132 FRRS) was 47.5
onths, with repetitive injury (n  82; 57.8%) as the
eading etiology. These patients had a low incidence of
omorbid conditions, including chronic pain syndromes,
uch as fibromyalgia and rheumatoid arthritis (14.1%); a
istory of neck and/or shoulder disease, such as disk de-
eneration, adhesive capsulitis, and rotator cuff tears
21.8%); and other systemic disease (4.2%). Beyond physi-
al therapy, preoperative interventions included injections
ith anesthetics and/or steroids (40.9%); surgery on the
eck, shoulder, chest, and/or wrist of the affected extrem-
ty (28.2%); Botox injections (19.7%) with reported relief in
4.3% of cases; and pain relief from opioids (31.0%). Sca-
ene block with bupivacaine tested surgical candidacy prior to
8.5%of FRRSprocedures,with 91.6%of recipients reporting
elief. Complications included persistent or severe postopera-
ive pain in the supraclavicular area or down the arm that did
ot resolve within 1 to 2 weeks of surgery or that occurred
econdary to muscle weakness (18.3%); persistent swelling in
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Volume 56, Number 4 Rochlin et al 1063the supraclavicular fossa, around the incision site, and/or in
the upper arm that did not resolve within several days of
surgery (2.8%); scar tissue in the supraclavicular fossa and/or
around the site of rib resection, detected by palpation and
patient report of tightness and discomfort (13.4%); reinjury
(4.2%); and pneumothorax (23.9%).
Unresolved symptoms. Twenty-four FRRS (23 pa-
tients) yielded unresolved symptoms at a mean of 16.1 
18
Unilateral
140/182 (77%)
Resolved
108/140 (77%)
Unresolved
17/140 (12%)
Recurrent
15/140 (11%
Fig 1. Overview of clinical classification
Table I. FRRSa demographic and clinical characteristics (b
Resolved Unre
FRRS 142 24
Mean age (years) 37.8 44
Mean length of symptoms (months) 47.5 89
Active smoker 19 (13.4%) 8 (3
Gender
Male 34 (23.9%) 5 (2
Female 108 (76.1%) 19 (7
Comorbid condition
Chronic pain syndrome 20 (14.1%) 16 (6
Neck/shoulder disease 31 (21.8%) 14 (5
Other disease 6 (4.2%) 3 (1
Cause
Repetitive injury 82 (57.8%) 10 (4
Trauma 60 (42.3%) 14 (5
Preoperative intervention
Injections 58 (40.9%) 15 (6
Surgery 40 (28.2%) 12 (5
Opioids 44 (31.0%) 16 (6
Scalene block
Bupivacaine 83 (58.5%) 15 (6
Relief 76 (91.6%) 14 (9
Botox 28 (19.7%) 11 (4
Relief 18 (64.3%) 2 (1
Complications
Pain 26 (18.3%) 19 (7
Swelling 4 (2.8%) 5 (2
Scar tissue 19 (13.4%) 5 (2
Reinjury 6 (4.2%) 1 (4
Pneumothorax 34 (23.9%) 8 (3
FRRS, First rib resection and scalenectomy; ns, not significant.
Percentages may not add up to 100 due to rounding.
aBilateral patients are included twice (per FRRS).14.7 postoperative months. Compared with successful out- (omes, these procedures were performed on patients who
ere older (mean age, 44.8 years; P .002), active smokers
33.3%; P  .031), with a longer length of symptoms at
nitial presentation (89.5 months; P  .005). Patients had
higher incidence of comorbid conditions, particularly
hronic pain syndromes (66.7%; P  .001) and neck
nd/or shoulder disease (58.3%; P  .001). Etiology fa-
ored trauma (58.3%) compared with repetitive injury
S
Bilateral
42/182 (23%) 
Resolved
34/42 (81%)
Unresolved
7/42 (17%)
Recurrent
1/42 (2%)
S, First rib resection and scalenectomy.
nical assessment) and P values
Recurrent
Three
outcomes
Resolved vs
unresolved
Resolved
vs
recurrent
16 — — —
39.3 .008 .002 ns
50.1 .020 .005 ns
1 (6.3%) .025 .031 ns
5 (31.3%) ns ns ns
11 (68.8%) — — —
6 (37.5%) .001 .001 .028
8 (50.0%) .001 .001 .027
0 (0%) ns ns ns
9 (56.3%) ns ns ns
7 (43.8%) — — —
6 (37.5%) ns ns ns
5 (31.3%) ns ns (.055) ns
6 (37.5%) .004 .001 ns
14 (87.5%) ns ns .029
14 (100%) ns ns ns
6 (37.5%) .011 .009 ns
3 (50.0%) .035 .014 ns
12 (75.0%) .001 .001 .001
1 (6.3%) .002 .004 ns
11 (68.8%) .001 ns .001
5 (31.3%) .001 ns .002
5 (31.3%) ns ns ns2 FRR
)y cli
solved
.8
.5
3.3%)
0.8%)
9.2%)
6.7%)
8.3%)
2.5%)
1.7%)
8.3%)
2.5%)
0.0%)
6.7%)
2.5%)
3.3%)
5.8%)
8.2%)
9.2%)
0.8%)
0.8%)
.2%)
3.3%)41.7%). Opioid use (66.7%; P  .001) and Botox injec-
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October 20121064 Rochlin et altions (45.8%; P  .009) were more common prior to
FRRS, with fewer cases of reported relief from Botox
(18.2%; P  .014). Complications associated with these
procedures more frequently included pain (79.2%; P 
.001) and swelling (20.8%; P .004). Postoperative inter-
ventions included physical therapy in all patients, in addi-
tion to anesthetic and/or steroid injections (37.5%), CT-
guided Botox injections (16.7%) without benefit reported
in any case, and other surgery such as shoulder arthroplasty
and neuroplasty of the brachial plexus (16.7%). At the end
of the follow-up period, only six (26.0%) patients achieved
freedom from opioid use, with one patient demonstrating
progressive resolution of symptoms.
Recurrent symptoms. Sixteen FRRS (16 patients)
yielded recurrent symptoms at a mean of 12.1 9.7 postop-
erative months, with a mean overall follow-up time of 21.3
14.2 months. Compared with successful outcomes, these
procedures were performed on patients with high rates of
chronic pain syndromes (37.5%; P .028) and neck and/or
shoulder disease (50.0%; P  .027). Complications more
frequently included pain (75.0%; P  .001), scar tissue
(68.8%; P .001), and reinjury often due to trauma (31.3%;
P  .002). Etiology favored repetitive injury (56.3%) com-
pared with trauma (43.8%). The main treatment modalities
were physical therapy (93.8%), CT-guided Botox injections
(37.5%) with benefit reported in 83.0% of cases, anesthetic
and/or steroid injections (18.8%), and other surgery such as
biceps tendonesis, acromioplasty, and discectomy (18.8%). At
the end of the follow-up period, 13 (81.3%) patients were free
from opioid use, with 11 patients demonstrating progressive
resolution of symptoms.
Contralateral symptoms. Twenty-one patients pre-
sented with contralateral symptoms prior to or after primary
FRRS and were treated with secondary FRRS at a mean of
15.0 months (range, 7-30 months) following initial surgical
intervention. As is shown in Table III, the average length of
symptoms was 49.8 months with a mean age of 38.7 years at
presentation. Etiology was more commonly repetitive injury
(66.7%) comparedwith trauma (33.3%). Patient demographic
and clinical characteristics, including gender, comorbid con-
ditions, preoperative interventions, outcome of scalene block,
Table II. Postoperative interventions and outcomes (by c
Unresolved
Total Improved
FRRS 24 1
Postoperative intervention
Physical therapy 24 (100%) 1 (100%)
Injections 9 (37.5%) 1 (100%)
Botox 4 (16.7%) 0 (0%)
Relief 0 (0%) 0 (0%)
Other surgery 4 (16.7%) 0 (0%)
Freedom from opioids 6 (25.0%) 1 (100%)
FRRS, First rib resection and scalenectomy.
aTwo unresolved and three recurrent outcomes unknown.and complications, did not differ significantly from the char- gcteristics of patients undergoing unilateral procedures. Fig 2
llustrates the breakdown of clinical classification for bilateral
atients, where 14 patients (28 FRRS) had resolved symp-
oms on both sides, four patients (eight FRRS) had resolved
ymptoms following primary FRRS andunresolved symptoms
ollowing secondary FRRS, and three patients (six FRRS) had
secondary FRRS following a primary FRRS that yielded
nresolved or recurrent symptoms. For bilateral procedures in
otal, 34 (81.0%) FRRS led to resolved symptoms, with seven
16.7%) FRRS leading to unresolved symptoms and one
2.4%) recurrent case (Fig 1). By the end of the follow-up
eriod, one (16.7%) patient with unresolved symptoms and
ne (100%) patient with recurrent symptoms achieved free-
om from opioids.
ISCUSSION
Though the main method of treatment for NTOS that
s refractory to conservative management, FRRS remains
ontroversial. Recent study of NTOS has largely focused on
emonstrating the benefits of surgical intervention, with
ittle effort to characterize the features and postoperative
ourse of patients who do not achieve adequate symptom
esolution. Although striving for surgical success, central
esponsibilities of the surgeon include preventing poor
utcomes by identifying factors predictive of failure and
romoting improvement among those who initially fail by
estructuring postoperative management.
The outcome of a scalene block with local anesthetic is
seful in predicting surgical candidacy, yet we have shown
hat patient demographic and clinical variables also play a
ignificant role in differentiating successful from failed sur-
ical outcomes. In our analysis of 182 FRRS performed at
ur institution, older age was significantly predictive of
oor outcome. This association of outcome with age re-
ects previously reported observations that FRRS was more
ikely to lead to symptom relief in NTOS patients aged40
ears compared with 40 years.7 Duration of symptoms
as similarly been presented as a predictor of surgical out-
ome, although both shorter (24 months) and longer
24 months) symptom length have been reported as
ignificantly predictive.8,9 Our finding of significantly lon-
l assessment)a
Recurrent
ot improved Total Improved Not improved
21 16 11 2
21 (100%) 15 (93.8%) 10 (90.9%) 2 (100.0%)
7 (33.3%) 3 (18.8%) 0 (0%) 1 (50.0%)
4 (19.0%) 6 (37.5%) 5 (45.5%) 1 (50.0%)
0 (0%) 5 (83.0%) 4 (80.0%) 1 (100%)
4 (19.0%) 3 (18.8%) 3 (27.3%) 0 (0%)
5 (23.8%) 13 (81.3%) 10 (90.9%) 1 (50.0%)linica
Ner symptom duration in unresolved cases supports the
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Volume 56, Number 4 Rochlin et al 1065latter observation, whereby prolonged compression of the
thoracic outlet may cause more extensive and irreversible
impairment due to scarring and reconditioning.
The association of unresolved symptoms with comor-
bid conditions, notably chronic pain syndromes and neck
and/or shoulder disease, is not surprising given the ten-
dency of these conditions to resemble NTOS. FRRS will
not benefit patients with fibromyalgia, degenerative disk
Table III. Patient demographic and clinical
characteristics (by number of sides)a
Unilateral Bilateral
N (patients) 140 21
Mean age (years) 38.8 38.7
Mean length of symptoms
(months) 51.7 49.8
Active smoker 20 (14.3%) 4 (19.1%)
Gender
Male 36 (25.7%) 4 (19.0%)
Female 104 (74.3%) 17 (81.0%)
Comorbid condition
Chronic pain syndrome 30 (21.4%) 6 (28.6%)
Neck/shoulder disease 40 (28.6%) 6 (28.6%)
Other disease 9 (6.4%) 0 (0%)
Cause
Repetitive injury 73 (52.1%) 14 (66.7%)
Trauma 67 (47.9%) 7 (33.3%)
Preoperative intervention
Injections 62 (44.3%) 9 (42.9%)
Surgery 49 (35.0%) 5 (23.8%)
Opioids 49 (35.0%) 9 (42.9%)
Scalene block
Bupivacaine 95 (67.9%) 13 (61.9%)
Relief 89 (93.7%) 11 (84.6%)
Botox 37 (26.4%) 5 (23.8%)
Relief 20 (54.1%) 2 (40.0%)
Complications
Pain 42 (30.0%) 8 (38.1%)
Swelling 7 (5.0%) 1 (4.8%)
Scar tissue 26 (18.6%) 5 (23.8%)
Reinjury 10 (7.1%) 0 (0%)
Pneumothorax 39 (27.9%) 3 (14.3%)
aNo comparisons were statistically significant at P  .05.
182 FRRS
Unilateral
140/182 (77%)
B
42/
28 Resolved/
Resolved
(67%; 14 patients)
8 Resolved/
Unresolved
(19%; 4 patients)
Fig 2. Clinical classification by side for bilateral first rib re
to 100 due to rounding. A forward slash is used to indicate the oisease, rotator cuff tears, or somatoform disorders instead
f true NTOS, even though they may present with weak-
ess, paresthesia, and pain in the upper extremity.10 Previ-
us investigation has documented unfavorable surgical
utcomes among patients with diffuse neurological or mo-
or symptoms and neck and/or shoulder pain.11-13 Our
nalysis supports this association, as the difference in the
ate of comorbidities affecting TOS-related regions was
ighly significant (P  .001) between cases of unresolved
nd resolved symptoms. This association may be reflective
f improper diagnosis or may suggest that comorbid con-
itions complicate recovery among true cases of NTOS.
Beyond patient demographics, preoperative interven-
ions and peri- or postoperative events were also predictive
f outcome. FRRS yielding unresolved symptoms was sig-
ificantly more likely to involve patients with a history of
pioid use; these patients were also more likely to have had
revious non-TOS surgery in the region of the neck and/or
pper extremity, although not at a level of significance (P
055). However, prior history of non-TOS surgery has
een significantly associated with poor outcomes in other
tudies, as have severe postoperative complications, such as
emothorax and nerve injury.9,11,13 Our finding of signif-
cantly higher rates of postoperative pain and swelling
mong unresolved cases identifies additional complications
hat characterize patients with a troubled recovery.
Active smoking status was also significantly associated
ith poor outcomes, a relationship that has been established
n other surgical contexts but not previously for NTOS.
mokers undergoing procedures ranging from plastic and
econstructive surgery to repair of tibia fractures have been
hown to have compromised healing and recovery.14,15 For
TOS patients undergoing FRRS in our study, active smok-
rs were significantly more common among cases of unre-
olved (33.3%) compared with resolved (13.4%) symptoms.
echanisms that may account for this association include
mpaired collagen production, immune dysregulation, and a
eakened cardiopulmonary system among smokers, although
moking may also serve as an indicator of unhealthy body
abits and inadequate compliancewith postoperative recovery
al
3%) 
resolved/
solved
1 patient)
2 Unresolved/
Unresolved 
(5%; 1 patient)
2 Recurrent/
Resolved
(5%; 1 patient)
n and scalenectomy (FRRS). Percentages may not add upilater
182 (2
2 Un
Re
(5%; 
sectio
utcomes of the first (left) and second (right) surgeries.
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tion prior to surgery have been shown to reduce surgical
morbidity, further underscoring the importance of smoking
intervention among NTOS surgical candidates.16
Additional patient factors not examined in our study
have also been associated with poor outcomes. These fac-
tors include psychological and social issues, including lower
educational achievement, single marital status, and depres-
sion.18 Workers’ compensation claims have variable rele-
vance based on a survey of pertinent literature; while some
analyses report worse outcomes among patients with work-
ers’ compensation insurance policies and complicated com-
pensation cases, others have documented no significant
association with surgical outcome.9,11,19-21 The associa-
tion of these variables with poor surgical results requires
further investigation and may be a worthy consideration
when setting expectations for recovery.
Similar to unresolved cases, FRRS procedures yielding
recurrent symptoms were associated with chronic pain syn-
dromes and neck and/or shoulder injury, and also with
postoperative complications. However, significantly associ-
ated complications unique to recurrent cases included scar
tissue and reinjury. These findings are in line with previous
reports of recurrence secondary to scar tissue, which may
occur as tissue contraction and adhesions within nerves of
the brachial plexus recreate the symptoms that were present
before surgery.9,22,23 Some studies also suggest that pa-
tients suffering reinjury have a better prognosis following
reintervention than those with scar tissue, emphasizing the
need for postoperative measures to prevent scar tissue
formation.9 It is important to note that several reports
include residual symptoms from incomplete prior FRRS
within the definition of recurrence.22-25 In our study, we
distinguished between recurrent and residual symptoms
and excluded the latter patient category from analysis.
Previous examinations of patients with symptomatic
contralateral NTOS have been limited to isolated case
reports, yet we report 21 patients treated with bilateral
FRRS for NTOS symptoms.26,27 We have shown that
patients with symptomatic contralateral NTOS were more
often engaged in chronic repetitive motion than traumatic
events but did not vary significantly from patients with
unilateral NTOS symptoms. TOS has been linked to vari-
ous anatomic abnormalities of the thoracic outlet with a
congenital or traumatic basis.28 In the case of a congenital
basis, it is logical to suspect that the abnormality may be
present bilaterally, yet this association has not been exten-
sively explored in the context of NTOS. Identifying pa-
tients likely to develop contralateral NTOS symptoms is a
challenge due to vague diagnostic criteria and is further
complicated by the lack of significant clinical differences
between patients undergoing unilateral and bilateral FRRS
procedures, as we have shown in this study.
Successful treatment of poor outcomes varies among
patients with unresolved, recurrent, and contralateral
symptoms and thus relies on correct assessment of symp-
tom type. In our study, the 23 patients with persistently
unresolved symptoms largely did not benefit from typical oostoperative treatment, including physical therapy and
njections in symptomatic regions. Four of these patients
nderwent additional non-TOS surgery for comorbid con-
itions, while three patients had postoperative diagnoses of
ystemic neurological or musculoskeletal disease, which
ncluded multiple sclerosis, Ehlers-Danlos syndrome, and
hronic inflammatory demyelinating neuropathy. The pres-
nce of these and other comorbid chronic pain and neck
nd/or shoulder diseases among the patient group with
nresolved symptoms highlights the importance of accu-
ate initial diagnosis and reconsideration of alternative
ymptom etiologies if resolution is not achieved following
RRS. Furthermore, the majority of these patients re-
ained dependent on opioids by the end of the follow-up
eriod, suggesting that pain management is a more appro-
riate intervention for this subset of patients.
In contrast to patients with unresolved symptoms, pa-
ients with recurrent symptoms are well managed with physi-
al therapy andCT-guidedBotox injections. Themassage and
otion exercises that comprise TOS-specific physical therapy
re key to releasing scar tissue and promoting neurovascular
obility and contributed to relief of symptoms in 90.9% of
ecurrent cases that were managed with this therapy.29 CT-
uided Botox injection into the anterior scalene muscle has
ecently gained favor as a method of pain relief for up to 3
onths in NTOS patients. Selective neuromuscular blockade
llows relaxation of the anterior scalene muscle, easing dis-
omfort associated with daily activities and facilitating the
ompletion of physical therapy protocols.30 Our finding of
elief following 83.0% of postoperative Botox injections
mong patients with recurrent symptoms supports the effec-
iveness of Botox injections as a management strategy for
ecurrent NTOS. Some authors have reported improvement
ollowing reoperation to correct recurrent symptoms, yet
hese findings were driven by patients with residual rib or
uscle remaining from a prior procedure.22,31 Excluding
atients with an incomplete prior FRRS, we have found that
atients with recurrent NTOS can be adequately managed
ith a conservative therapeutic course of physical and injec-
ion therapy.
Patients with contralateral symptoms can be effectively
reated with a secondary FRRS at least 1 year after the
rimary procedure. A waiting period of 1 year is necessary
o ensure sufficient recovery from the initial FRRS. In our
tudy, while most cases of successful primary surgery were
ollowed by successful contralateral surgery, there were
our cases of unresolved symptoms after successful con-
ralateral FRRS that resulted from events such as complica-
ions (eg, postoperative bleeding) or significant one-sided
omorbidity (eg, temporomandibular joint disorder). The
wo cases in which a failed primary surgery was followed by
contralateral surgery were performed on patients who had
xhausted all other therapeutic options or who did not have
ndicators suggesting a similar poor outcome on the con-
ralateral side. Overall, most patients undergoing bilateral
rocedures had successful outcomes on both sides.
Limitations to our study include the subjective nature
f symptom categorization and measures of improvement.
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remains a challenge to NTOS in general due to the lack of
objective assessment measures. Additional limitations in-
clude the retrospective study design, as data on patient
demographics, preoperative status, and postoperative com-
plications were gathered only by review of patient charts.
In conclusion, we have described the characteristics and
management of NTOS patients with unresolved, recurrent,
and/or contralateral symptoms following FRRS. Patients
with unresolved symptoms aremore often older, active smok-
ers with an increased frequency of comorbid pain syndromes,
neck and/or shoulder disease, and a longer period of symp-
toms. These factors should be considered when determining
surgical candidacy. Traditional physical and injection therapy
is not sufficient postoperative treatment for this troubled
subset, which instead requires interventions aimed at long-
termpainmanagement. In contrast, patientswith initial symp-
tom improvement followed by recurrence, often secondary to
scar tissue and reinjury, can be effectively treated with physical
therapy and CT-guided Botox injections. Patients with con-
tralateral symptoms arewellmanagedwith secondary FRRS at
more than 1 year after primary surgery. Overall, our findings
suggest that patients must be followed closely after FRRS to
determine if additional interventions are necessary to ensure a
successful postoperative course.
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BDISCUSSION
DrMarcMitchell (Jackson, Miss). This is another in a series of
papers from the Johns Hopkins University regarding thoracic
outlet syndrome. The current paper is a retrospective review of 161
patients who underwent 182 first rib resections with scalenectomy.
Like their other series, the results in this one are quite admirable,
with between 70% and 80% of patients with unilateral and bilateral
operations having resolution of their symptoms. This series specif-
ically looks at patients who had a poor outcome as defined by lack
of resolution of symptoms or recurrent symptoms. I have four
questions.
You mentioned that all the patients failed preoperative physi-
cal therapy. Physical therapy was also the mainstay of therapy for
patients who had residual or recurrent symptoms following sur-
gery. Do you have any details regarding the preoperative physical
therapy? Specifically, the response to preoperative therapy and its
relationship to the response to postoperative therapy.
One would think that successful surgery on the first side would
be a good predictor of success on the other side. In this series, that
was not the case. The failure rate in patients who had a successful
operation on one side followed by a second operation on the other
side was the same as those who had a unilateral procedure. Can you
speculate why?
Were you able to identify a constellation of preoperative risk
factors that reliably predicted unsuccessful surgery? For instance,
were all the smokers with chronic pain symptoms destined to fail?
You have convinced me that patients with these risk factors are
poor surgical candidates. Would you operate on a 45-year-old
smoker with symptoms for 8 years who takes narcotics for
chronic pain syndrome?
I would like to congratulate the authors on an excellent paper
and presentation and thank them for providing themanuscript well
in advance of themeeting. I would also like to thank the association
for the opportunity to discuss this paper.Danielle H. Rochlin. I will begin by addressing the first
question about factors related to physical therapy that may be
o
bssociated with surgical outcome. We have not identified any
articular elements of the physical therapy protocol that affect
utcome, although we have observed that a substantial majority of
atients have successful outcomes with postoperative physical ther-
py alone, despite failing preoperative physical therapy. This is
ecause we have performed surgery to remove the first rib, thereby
ecompressing the thoracic outlet and making patients more able
o complete the physical therapy protocol.
Your second question asks why some patients have a successful
utcome on one side and then a failure on the next side. This
attern was seen for only four patients, which is too few to allow us
o draw a definitive conclusion. However, some factors that may
ontribute to this finding are that patients might be less motivated
o complete a second round of physical therapy, or there might be
significant one-sided comorbidity that would have caused a
atient to fail on one side and not the second side. For example, I
ecall one patient that had a significant temporomandibular joint
roblem on one side that was not present on the other. Generally,
e aim to choose patients for surgery who will likely have a
avorable outcome on the second side, and this is indeed the
utcome in the majority of cases.
Regarding the question about whether we have identified any
onstellations of symptoms that predict poor outcome, we have
ot run an analysis that would allow me to answer that question.
e would need to do a multivariate analysis to determine which
actors are predictive in combination.
Lastly, concerning the decision to operate on a patient who
as several predictors of poor outcomes, I would not operate
oluntarily. We are actually planning a study to investigate more
onservative ways of managing these patients. In our prospec-
ive clinical trial that is currently in development, patients will
e randomized to either first rib resection and scalenectomy or
otox injections every 3 months for 1 year. We hypothesize that
lder patients with predictors of poor outcomes will perform
etter with Botox injections.
